FindTrial
Sign In

Evaluation of blood derived growth factor release from varied types of blood products

Evaluation of platelet derived growth factor release from injectable T-PRF and comparison with varied preparations of platelet concentrates - An In vitro study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034112
Enrollment
6
Registered
2021-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Mounika Reddy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers will be selected after a routine haematological evaluation, who presented with no abnormal findings

Exclusion criteria

Exclusion criteria: Patients with history of any systemic disorder, bleeding , platelet disorder, abnormal haematological findings, who are under anticoagulant therapy or on anti-platelet drugs and smokers

Design outcomes

Primary

MeasureTime frame
Measuring the amount of PDGF-AA release from i-TPRF, PRF, i-PRF and T-PRFTimepoint: 2h hours—

Secondary

MeasureTime frame
Measuring the amount of PDGF-AA release from i-TPRF, PRF, i-PRF and T-PRFTimepoint: 7th day—

Countries

India

Contacts

Public ContactDr Pratibha

Manipal college of dental college

pratibha.pk@manipal.edu9448724121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026